Brief report · 30 Jun 2026
Conference abstractPublished 15 Oct 2013
Unravelling the human multidrug resistance P-glycoprotein poly-specificity
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
One main mechanism of drug resistance involves multi-drug efflux pumps which expel drugs out of the cells. How these proteins pump out hundreds of toxins, and among them anticancer drugs, while displaying marked specificities is mysterious. We bring here a molecular basis of this mechanism of poly-specificity, having localized the H- and R-sites of the human P-gp, two main sites by which drugs efflux occurs, here exemplified with Hoechst 33342 and daunorubicin. We achieved this by characterizing in cellulo inhibition mechanisms of the selenohexapeptide inhibitor QZ59 enantiomers, the first compounds ever co-crystallized with the mouse P-gp(2), combining these data with the structural analysis of the conformations recently reported(3). Results show that the SSS QZ59 enantiomer competitively inhibits Hoechst 33342 and daunorubicin transports, with K I,app of 0.15 and 0.3 μM respectively, 13 and 2 times lower than corresponding K m,app . QZ59-RRR in contrast non-competitively inhibited drugs transport, with a moderate efficacy (K I,app ≥1.6 μM) but became competitive towards Hoechst 33342 at high concentrations (K I,app ~5 μM). This suggests a positional QZ59 groove drugs transport sites overlap, full for the H-site and partial for the R-site. The latter may share the most embedded QZ59-SSS location as supported by docking analyses. These results will guide the design of compounds acting at the molecular level to block P-gp-mediated drug efflux with the highest efficiency.
Subjects
ChemistryPharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Medicinal Chemistry.
Commentary · 29 Dec 2025
Accelerating Drug Discovery: Molecular Docking and Virtual Screening
Opinion · 29 Dec 2025
Pharmacophore Modeling: A Cornerstone of Drug Discovery
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedicinal Chemistry
- SubjectChemistry
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Pierre Falson”
- BylineArticles whose byline prints “Lorena Martinez”
- BylineArticles whose byline prints “Ophélie Arnaud”
- BylineArticles whose byline prints “Emilie Henin”
- BylineArticles whose byline prints “Vincent Chaptal”
- BylineArticles whose byline prints “RupakDoshi”
- BylineArticles whose byline prints “HochaoTao”
- BylineArticles whose byline prints “Michel Tod”
